The review discusses fifty eight peptides in several clinical phases, indicating a robust pipeline of peptide therapies focusing on PPIs. These approaches open new avenues for remedies customized to battle precise breast cancer subtypes and glioblastoma by honing in on integrins, fibronectins, and matrix metalloproteinases. Similarities and variances in between https://jinnahi009lyi4.wikigop.com/user